#University of Pennsylvania

Using organs from donors with hepatitis C could significantly cut down waiting lists, with little risk of infection.

The experimental surgeries could help open up an entirely new pool of donor organs for those in need of a transplant.

Researchers say offering patients a new kidney years sooner but with a treatable infection is likely to save many lives.

HIV ramps up liver disease progression among those coinfected with hepatitis C, even in the face of antiretroviral treatment for HIV.

AbbVie’s investigational triple-combination therapy cured close to 100 percent of people with genotype 1b.